P2RY12 and atrial fibrillation: Failure to be discharged on a P2Y12 inhibitor (which may occur in some who receive dual anti-thrombin therapy with aspirin and concomitant anticoagulant therapy for AF, for example) also predicted late unplanned readmission, perhaps due to an increased risk of ischaemic events.